1. Home
  2. AIMD vs GSIW Comparison

AIMD vs GSIW Comparison

Compare AIMD & GSIW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AIMD
  • GSIW
  • Stock Information
  • Founded
  • AIMD 1984
  • GSIW 2016
  • Country
  • AIMD United States
  • GSIW Hong Kong
  • Employees
  • AIMD N/A
  • GSIW 17
  • Industry
  • AIMD Biotechnology: Pharmaceutical Preparations
  • GSIW
  • Sector
  • AIMD Health Care
  • GSIW
  • Exchange
  • AIMD Nasdaq
  • GSIW Nasdaq
  • Market Cap
  • AIMD 8.5M
  • GSIW 12.3M
  • IPO Year
  • AIMD N/A
  • GSIW 2023
  • Fundamental
  • Price
  • AIMD $0.62
  • GSIW $0.79
  • Analyst Decision
  • AIMD
  • GSIW
  • Analyst Count
  • AIMD 0
  • GSIW 0
  • Target Price
  • AIMD N/A
  • GSIW N/A
  • AVG Volume (30 Days)
  • AIMD 1.3M
  • GSIW 11.3M
  • Earning Date
  • AIMD 03-07-2025
  • GSIW 12-31-2024
  • Dividend Yield
  • AIMD N/A
  • GSIW N/A
  • EPS Growth
  • AIMD N/A
  • GSIW N/A
  • EPS
  • AIMD N/A
  • GSIW N/A
  • Revenue
  • AIMD $40,633.00
  • GSIW $1,313,795.00
  • Revenue This Year
  • AIMD N/A
  • GSIW N/A
  • Revenue Next Year
  • AIMD N/A
  • GSIW N/A
  • P/E Ratio
  • AIMD N/A
  • GSIW N/A
  • Revenue Growth
  • AIMD N/A
  • GSIW N/A
  • 52 Week Low
  • AIMD $0.40
  • GSIW $0.43
  • 52 Week High
  • AIMD $3.10
  • GSIW $15.45
  • Technical
  • Relative Strength Index (RSI)
  • AIMD 48.56
  • GSIW 64.32
  • Support Level
  • AIMD $0.57
  • GSIW $0.44
  • Resistance Level
  • AIMD $0.87
  • GSIW $0.51
  • Average True Range (ATR)
  • AIMD 0.09
  • GSIW 0.11
  • MACD
  • AIMD -0.02
  • GSIW 0.01
  • Stochastic Oscillator
  • AIMD 17.45
  • GSIW 43.39

About AIMD Ainos Inc.

Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low-dose oral form. Its product pipeline includes VELDONA Pet cytoprotein supplements for pets, VELDONA human therapeutics for clinical use, and telehealth-friendly POCTs powered by the AI Nose technology platform.

About GSIW Garden Stage Limited

Garden Stage Ltd is a Hong Kong-based financial services provider principally engaged in the provision of placing and underwriting services; securities dealing and brokerage services; and asset management services. Its business is carried out through its wholly owned Operating Subsidiaries: a) I Win Securities, which is licensed to conduct Type 1 (dealing in securities) regulated activities under the SFO in Hong Kong, and b) I Win Asset Management, which is licensed to conduct Type 4 (advising on securities) and Type 9 (asset management) regulated activities under the SFO in Hong Kong.

Share on Social Networks: